Research progress of presepsin: a newly identified soluble CD14 subtype as a marker for sepsis

doi:10.3877/cma.j.issn.2096-1537.2017.03.005

Abstract

Abstract:

Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated host response to infection, which is the leading cause of death in critically ill patients in intensive care unit (ICU). Circulating bio-markers are helpful in early diagnosis of sepsis, evaluating the severity, guiding antimicrobials management and predicting outcomes. Unlike procalcitonin, interleukin-6 or C-reactive protein, an newly discovered bio-marker ″Presepsin″ has been shown as a useful effect on early diagnosis and accessment of sepsis, which will become to be a prospective clinical application.

Key words: Sepsis, Septic shock, sCD14-ST, Presepsin

Liren Lai. Research progress of presepsin: a newly identified soluble CD14 subtype as a marker for sepsis[J]. Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition), 2017, 03(03): 178-181.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://icu.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2096-1537.2017.03.005

https://icu.cma-cmc.com.cn/EN/Y2017/V03/I03/178

References 31

1	American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis[J]. Crit Care Med, 1992, 20(6): 864-874.
2	Rhodes A, Evans LE, Alhazzani W, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016[J]. Intensive Care Med, 2017, 43(3): 304-377.
3	Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)[J]. JAMA, 2016, 315(8): 801-810.
4	Wacker C, Prkno A, Brunkhorst FM, et al. Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis[J]. Lancet Infect Dis, 2013, 13(5): 426-435.
5	Yang Y, Xie J, Guo F, et al. Combination of C-reactive protein, procalcitonin and sepsis-related organ failure score for thediagnosis of sepsis in critical patients[J]. Ann Intensive Care, 2016, 6(1): 51.
6	Oliveira CF, Botoni FA, Oliveira CR, et al. Procalcitonin versus C-reactive protein for guiding antibiotic therapy in sepsis: a randomized trial[J]. Crit Care Med, 2013, 41(10): 2336-2343.
7	Klag T, Cantara G, Sechtem U, et al. Interleukin-6 Kinetics can be Useful for Early Treatment Monitoring of Severe Bacterial Sepsis and Septic Shock[J]. Infect Dis Rep, 2016, 8(1): 6213.
8	Maier M, Wutzler S, Lehnert M, et al. Serum procalcitonin levels in patients with multiple injuries including visceral trauma[J]. J Trauma, 2009, 66(1): 243-249.
9	Shirakawa K, Furusako S, Endo S, et al. New diagnostic marker for sepsis: soluble CD14 subtype[J]. Crit Care, 2004, 8 (Suppl 1): P191.
10	Yaegashi Y, Shirakawa K, Sato N, et al. Evaluation of a newly identified soluble CD14 subtype as a marker for sepsis[J]. J Infect Chemother, 2005, 11(5): 234-238.
11	Liu S, Khemlani LS, Shapiro RA, et al. Expression of CD14 by hepatocytes: upregulation by cytokines during endotoxemia[J]. Infect Immun, 1998, 66(11): 5089-5098.
12	Grunwald U, Krüger C, Westermann J, et al. An enzyme-linked immunosorbent assay for the quantification of solubilized CD14 in biological fluids[J]. J Immunol Methods, 1992, 155(2): 225-232.
13	Landmann R, Zimmerli W, Sansano S, et al. Increased circulating soluble CD14 is associated with high mortality in gram-negative septic shock[J]. J Infect Dis, 1995, 171(3): 639-644.
14	Shirakawa K, Naitou K, Hirose J, et al. The new sepsis marker, sCD14-ST, induction mechanism in the rabbit sepsis models[J]. Crit Care, 2010, 14 (Suppl 2): P19.
15	Shozushima T, Takahashi G, Matsumoto N, et al. Usefulness of presepsin (sCD14-ST) measurements as a marker for the diagnosis and severity of sepsis that satisfied diagnostic criteria of systemic inflammatory response syndrome[J]. J Infect Chemother, 2011, 17(6): 764-769.
16	Nakamura M, Takeuchi T, Naito K, et al. Early elevation of plasma soluble CD14 subtype, a novel biomarker for sepsis, in a rabbit cecal ligation and puncture model[J]. Crit Care, 2008, 12 (Suppl 2): P194.
17	Okamura Y, Yokoi H. Development of a point-of-care assay system for measurement of presepsin (sCD14-ST)[J]. Clin Chim Acta, 2011, 412(23-24): 2157-2161.
18	Behnes M, Bertsch T, Lepiorz D, et al. Diagnostic and prognostic utility of soluble CD 14 subtype (presepsin) for severe sepsis andseptic shock during the first week of intensive care treatment[J]. Crit Care, 2014, 18(5): 507.
19	Ulla M, Pizzolato E, Lucchiari M, et al. Diagnostic and prognostic value of presepsin in the management of sepsis in the emergency department: a multicenter prospective study[J]. Crit Care, 2013, 17(4): R168.
20	Endo S, Suzuki Y, Takahashi G, et al. Usefulness of presepsin in the diagnosis of sepsis in a multicenter prospective study[J]. J Infect Chemother, 2012, 18(6): 891-897.
21	Liu B, Chen YX, Yin Q, et al. Diagnostic value and prognostic evaluation of Presepsin for sepsis in an emergency department[J]. Crit Care, 2013, 17(5): R244.
22	Carpio R, Zapata J, Spanuth E, et al. Utility of presepsin (sCD14-ST) as a diagnostic and prognostic marker of sepsis in the emergency department[J]. Clin Chim Acta, 2015, 450: 169-175.
23	Sato R, Suzuki Y, Sato M, et al. Serum levels of presepsin reflects the APACHE II and SOFA scores inpatients with sepsis[J]. Crit Care, 2013, 17 (Suppl 2): P37.
24	Zheng Z, Jiang L, Ye L, et al. The accuracy of presepsin for the diagnosis of sepsis from SIRS: a systematic review and meta-analysis[J]. Ann Intensive Care, 2015, 5(1): 48.
25	Tong X, Cao Y, Yu M, et al. Presepsin as a diagnostic marker for sepsis: evidence from a bivariate meta-analysis[J]. Ther Clin Risk Manag, 2015, 11: 1027-1033.
26	Masson S, Caironi P, Fanizza C, et al. Circulating presepsin (soluble CD14 subtype) as a marker of host response in patients withsevere sepsis or septic shock: data from the multicenter, randomized ALBIOS trial[J]. Intensive Care Med, 2015, 41(1): 12-20.
27	Endo S, Suzuki Y, Takahashi G, et al. Presepsin as a powerful monitoring tool for the prognosis and treatment of sepsis: a multicenter prospective study[J]. J Infect Chemother, 2014, 20(1): 30-34.
28	Masson S, Caironi P, Spanuth E, et al. Presepsin (soluble CD14 subtype) and procalcitonin levels for mortality prediction in sepsis:data from the Albumin Italian Outcome Sepsis trial[J]. Crit Care, 2014, 18(1): R6.
29	Nakamura Y, Ishikura H, Nishida T, et al. Usefulness of presepsin in the diagnosis of sepsis in acute kidney injury patients[J]. Crit Care, 2013, 17(Suppl 2): P36.
30	Nakamura Y, Ishikura H, Nishida T, et al. Usefulness of presepsin in the diagnosis of sepsis in patients with or without acute kidney injury[J]. BMC Anesthesiol, 2014, 14: 88.
31	Chenevier-Gobeaux C, Trabattoni E, Roelens M, et al. Presepsin (sCD14-ST) in emergency department: the need for adapted threshold values? [J]. Clin Chim Acta, 2014, 27: 34-36.

[1]	Yan Zhuang, Linfeng Dai, Haidong Zhang, Qiuhua Chen, Qingfang Nie. Risk factors of early survival for sepsis patients and construction of a Cox risk prediction model [J]. Chinese Journal of Critical Care Medicine(Electronic Edition), 2024, 17(05): 372-378.
[2]	Jin Yang, Xueke Liu, Yuanyuan Zhang, Jun Jin, Yao Wei. Protective effect of gut microbiota-derived lithocholic acid on sepsis-associated hepatic injury [J]. Chinese Journal of Critical Care Medicine(Electronic Edition), 2024, 17(04): 265-274.
[3]	Xia Zhang, Rui Zhang, Zhibo Zheng, Qin Zhang. Shikonin improves prognosis of mice with sepsis-induced cardiomyopathy by modulating lactylation and mitochondrial function [J]. Chinese Journal of Critical Care Medicine(Electronic Edition), 2024, 17(04): 275-284.
[4]	Jingqi Zhang, Yang Jiang, Jialu Sun, Xingzhe Tang, Yufei Zhao, Ying Cui, Xinxiang Li, Jingyue Dai, lin Fu, Xingui Peng. Early identification of sepsis with acute kidney injury by perirenal CT features combined with serum creatinine [J]. Chinese Journal of Critical Care Medicine(Electronic Edition), 2024, 17(04): 285-292.
[5]	Zhenhe Li, Changqing Wei, Guodong Zhen, Zhenfu Li. Changes of serum S1P and Wnt5a in patients with sepsis complicating acute respiratory distress syndrome and their clinical significance [J]. Chinese Journal of Critical Care Medicine(Electronic Edition), 2024, 17(04): 293-300.
[6]	Heng Fan, Min Sun, Jianhua Zhu. Protective effect of salidroside on septic acute kidney injury in rats by inhibiting phosphatidylinositol 3 kinase/protein kinase B/mammalian target of rapamycin signal pathway [J]. Chinese Journal of Critical Care Medicine(Electronic Edition), 2024, 17(03): 188-195.
[7]	Baoping Xu, Huaiwen Peng, Huaibin Yu, Xiaotao Wang. A case of diabetic ketoacidosis with hepatic portal vein gas secondary to corona virus disease 2019 [J]. Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition), 2024, 18(04): 250-255.
[8]	Boxing Su, Bo Xiao, Jianxing Li. Hot research and interpretation of surgical therapy for stone disease in the annual meeting of American Urology Association in 2024 [J]. Chinese Journal of Endourology(Electronic Edition), 2024, 18(04): 303-308.
[9]	Force on Experts Consensus on Extended Infusion of β-Lactam Task. Experts consensus on extended infusion of β-lactam antibiotics in adult sepsis patients [J]. Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition), 2024, 10(04): 313-324.
[10]	Xi Chen, Zongsheng Wu, Mingzhu Zheng, Haibo Qiu. Research progress in sepsis immune disorder: thymic atrophy [J]. Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition), 2024, 10(04): 379-383.
[11]	Xiang Yang, Lanqi Guo, Jianfeng Xie, Haibo Qiu. Advances in transcriptomics in diagnosis and management of sepsis [J]. Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition), 2024, 10(04): 384-388.
[12]	Runshi Zhou, Min Zheng, Wei Han, Zunzhu Li, Chaokai He, Yi Chi, Yun Long. Effect of cluster goal-oriented nursing strategy on the 28-day prognosis of patients with septic shock caused by multi-drug resistant bacteria [J]. Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition), 2024, 10(03): 236-242.
[13]	Zihan Hu, Fei Peng, Qin Sun, Yi Yang. Research progress of extracellular vesicles in vascular endothelial dysfunction in sepsis [J]. Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition), 2024, 10(03): 265-270.
[14]	Huiying Chen, Minshan Qiu, Hanquan Shao. Construction and application effect of risk factor model for intestinal mucosal barrier function damage induced by sepsis [J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2024, 14(05): 448-452.
[15]	Jingni Xi, Na Li, Qi Zhang. Predictive value of neutrophil-to-lymphocyte ratio for progression of severe community-acquired pneumonia to sepsis in elderly patients [J]. Chinese Journal of Geriatrics Research(Electronic Edition), 2024, 11(03): 28-31.

Please choose a citation manager

Content to export